Evaluation of a job retention program for breast cancer survivors
Realistic Evaluation of a Job Retention Program After Breast Cancer
This study is testing a job support program to help women aged 18 to 55 who have survived breast cancer return to work and stay employed after their treatment.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 215 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Hospices Civils de Lyon Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Lyon) |
| Trial ID | NCT05919498 on ClinicalTrials.gov |
What this trial studies
This observational study evaluates a job retention program aimed at helping women aged 18 to 55 who have been diagnosed with invasive breast cancer return to and maintain employment after treatment. The study involves individual semi-directive interviews and focus groups to gather insights on the challenges faced by these women, including the impact of cancer and its treatment on their ability to work. By identifying barriers and facilitators to job retention, the program seeks to improve social participation and financial independence for breast cancer survivors.
Who should consider this trial
Good fit: Ideal candidates for this study are women aged 18 to 55 who have been diagnosed with invasive breast cancer and are currently employed.
Not a fit: Patients who are not currently employed or who do not meet the specific inclusion criteria related to their cancer treatment may not benefit from this study.
Why it matters
Potential benefit: If successful, this program could enhance the ability of breast cancer survivors to return to work, thereby improving their quality of life and reducing social costs associated with cancer.
How similar studies have performed: While similar studies have explored job retention for cancer survivors, this specific evaluation of the FASTRACS-RCT intervention is novel in its approach.
Eligibility criteria
Show full inclusion / exclusion criteria
* Inclusion Criteria concerning FASTRACS-RCT participants (groupe 1) \* : * Patients included in the intervention arm of the "FASTRACS-RCT" trial who have completed their participation in the trial. * Woman aged between 18 and 55. * With a diagnosis of invasive breast carcinoma of stage cTNM or pTNM stage I to III (UICC 8th edition), confirmed on histological examination. * Treated by intravenous cytotoxic chemotherapy in an adjuvant or neoadjuvant situation. * Breast surgery +/- of the axillary area, carried out within 3 months preceding the start of adjuvant chemotherapy, or scheduled after neoadjuvant chemotherapy +/- radiotherapy. * In salaried employment at the time of diagnosis (permanent or temporary contract, interim assignment, civil servant). * Affiliated to a French social security scheme. * Reading, understanding, and writing the French language. * Followed in one of the investigating centers. * Not opposing the collection data. * Inclusion Criteria \* : * Persons declared by the patients for the study of the trajectories and only if their agreement is obtained for each person concerned (general practitioner, occupational physician, personnel of the resource center fort occupational and environmental pathologies (CRPPE), colleagues and hierarchy in the company and any key person identified by the patient who participated in the recovery process using the intervention tools).(groupe 2) * Participants in discussion groups independent of trajectories (oncologists, clinical research associates, general practitioners, occupational health teams and CRPPE staff). (Groupe 3) * For all categories of participants, it is necessary to be of legal age, to be able to read, understand and speak French. * Exclusion Criteria concerning FASTRACS-RCT participants (groupe 1)\* : * In situ carcinoma. * Distant metastases. * History or co-existence of another primary cancer (apart from a basal cell cancer of the skin and/or non-mammary cancer in complete remission for more than 5 years). * Recurrence or second breast cancer. * Without employment contract, self-employed or supported contract. * Cannot be followed for the duration of the study, for medical, social, family, geographical or psychological reasons. * Deprived of liberty by court or administrative decision. * Exclusion Criteria \* : * No exclusion criteria concern participants related to patients (declared by patients) (groupe 2). * No exclusion criteria for the people delivering the intervention (focus group participants) (groupe 3).
Where this trial is running
Lyon
- Pôle de Santé Publique des Hospices Civils de Lyon — Lyon, France (Recruiting)
Study contacts
- Study coordinator: Marion LAMORT BOUCHE, MD
- Email: marion.lamort-bouche@univ-lyon1.fr
- Phone: 04 72 11 28 04
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.